دورية أكاديمية

Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease.

التفاصيل البيبلوغرافية
العنوان: Insulin receptor substrate 2 gene Gly1057Asp polymorphism is a risk factor for nonalcoholic fatty liver disease.
المؤلفون: Nouri, Shadi, Mahmoudi, Touraj, Hojjati, Farzaneh, Najafabadi, Zeinab Nourmohammadi, Shafiee, Radmehr, Sayedsalehi, Shiva, Dehghanitafti, Atefeh, Ardalani, Abbas, Kohansal, Kiarash, Rezamand, Gholamreza, Asadi, Asadollah, Nobakht, Hossein, Dabiri, Reza, Farahani, Hamid, Tabaeian, Seidamir Pasha, Zali, Mohammad Reza
المصدر: Laboratory Medicine; Mar2024, Vol. 55 Issue 2, p215-219, 5p
مصطلحات موضوعية: GENETICS of disease susceptibility, NON-alcoholic fatty liver disease, RISK assessment, CARRIER proteins, RESEARCH funding, T-test (Statistics), POLYMERASE chain reaction, CHI-squared test, DESCRIPTIVE statistics, GENETIC polymorphisms, RESEARCH, DATA analysis software, CONFIDENCE intervals, SINGLE nucleotide polymorphisms, DISEASE risk factors
مستخلص: Objective Nonalcoholic fatty liver disease (NAFLD), which is an emerging global chronic liver disease, has a close association with insulin resistance. We aimed to determine whether the Gly1057Asp (rs1805097) polymorphism of the insulin receptor substrate 2 (IRS2) gene is associated with NAFLD. Methods Using the polymerase chain reaction-restriction fragment length polymorphism method, 135 patients with biopsy-proven NAFLD and 135 controls underwent IRS2 genotype analysis. Results Genotype and allele distributions of the IRS2 gene Gly1057Asp variant conformed to the Hardy-Weinberg equilibrium in both the case and control groups (P >.05). The Asp/Asp genotype of IRS2 gene Gly1057Asp polymorphism compared with Gly/Gly genotype was associated with a 2.1-fold increased risk for NAFLD after adjustment for confounding factors (P =.029; odds ratio = 2.10, 95% CI = 1.23-3.97). Conclusion Our findings revealed for the first time that the Gly1057Asp Asp/Asp genotype of the IRS2 gene is a marker of increased NAFLD susceptibility; however, studies in other populations are required to confirm the results. [ABSTRACT FROM AUTHOR]
Copyright of Laboratory Medicine is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:00075027
DOI:10.1093/labmed/lmad066